Sana biotechnology stock.

$-1.44 Market Cap $827.96 M Shares Outstanding 197.13 M Public Float 98.87 M Yield SANA is not currently paying a regular dividend. Latest Dividend N/A Ex …Nov 8, 2023 · SEATTLE, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today reported financial ... SEATTLE, Dec. 11, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, shared data in six presentations at the 64 th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place from Saturday, December 10 to Tuesday, …In a report released today, Emily Bodnar from H.C. Wainwright reiterated a Hold rating on Sana Biotechnology ( SANA – Research Report ). The company’s shares closed yesterday at $7.09. Bodnar ...Nov 27, 2023 · View Sana Biotechnology, Inc SANA investment & stock information. Get the latest Sana Biotechnology, Inc SANA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Over the past 30 days, the shares of Sana Biotechnology Inc (NASDAQ:SANA) have changed 30.74%. Short interest in the company has seen 21.6 million shares shorted with days to cover at 14.75. Wall Street analysts have a consensus price target for the stock at $8.80, which means that the shares’ value could jump 54.09% from current levels.The company, currently valued at $43.28M, closed the last trade at $0.21 per share which meant it gained $0.01 on the day or 3.08% during that session. The BHIL stock price is -1376.19% off its 52-week high price of $3.10 and 33.33% above the 52-week low of $0.14. If we look at the company’s 10-day average daily trading volume, we find that ...

Sana Biotechnology's stock was trading at $3.95 at the start of the year. Since then, SANA shares have increased by 2.8% and is now trading at $4.06. View the …

General and administrative expenses for the three and six months ended June 30, 2022 include stock-based compensation of $2.5 million and $4.5 million, respectively, and $1.8 million and $3.3 million for the same periods in 2021. Net Loss: Net loss for the three and six months ended June 30, 2022 was $72.5 million, or $0.39 per share, ...Dec 1, 2023 · Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and ... SEATTLE, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the publication in Blood of an abstract providing initial clinical data from the first patient treated at the lowest dose in the ongoing ARDENT Phase 1 clinical trial with …At the start of 2013, when the pace of new stock offerings quickened, shares in the XBI biotech stock index were worth $30. Eight years later, they reached $174. ... For example, Sana Biotechnology and Lyell Immunopharma, both cell therapy developers, raised more than $1 billion combined last year in two of the sector's largest biotech IPOs ...

Stock Price. $4.3. 2023-11-22. Market Capitalization. $837.8 M. 2023-11-22. Sana Biotechnology Summary. Company Summary. Overview. Sana Biotechnology is a company specializing in cell and gene therapy. It focuses on creating and delivering engineered cells as medicines for patients. The company deploys a platform that can …

Over the past week, Wood has been accumulating shares of Verve Therapeutics (VERV-6.12%) for her firm's flagship growth stock fund, the ARK Innovation ETF (ARKK 0.43%), and the biotech-focused ARK ...

Nov 30, 2022 · Cell therapy and gene repair company Sana Biotechnology Inc., which raised nearly $600 million in an IPO at the height of the biotech boom, said Tuesday it plans to cut about 15% of its workforce. Stock Price. $4.3. 2023-11-22. Market Capitalization. $837.8 M. 2023-11-22. Sana Biotechnology Summary. Company Summary. Overview. Sana Biotechnology is a company specializing in cell and gene therapy. It focuses on creating and delivering engineered cells as medicines for patients. The company deploys a platform that can …The LSDI stock price is -1804.76% off its 52-week high price of $4.00 and 19.05% above the 52-week low of $0.17. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.44 million shares traded. The 3-month trading volume is 228.11K shares. The consensus among analysts is that Lucy Scientific …Find real-time SANA - Sana Biotechnology Inc stock quotes, company profile, news and forecasts from CNN Business. Dec 1, 2023 · SEATTLE, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced the ... 1.45%. $369.91M. SANA | Complete Sana Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Nov 28, 2023 · The Sana Biotechnology, Inc. stock price gained 7.14% on the last trading day (Friday, 17th Nov 2023), rising from $3.92 to $4.20. During the last trading day the stock fluctuated 9.62% from a day low at $3.90 to a day high of $4.28. The price has risen in 6 of the last 10 days and is up by 18.98% over the past 2 weeks.

Oct 11, 2023 · Seattle-based Sana went public just as the biotech stock market peaked in February 2021, enabling it to raise $587.5 million before entering the clinic. The stock has followed the broader market ... License will enable Sana’s in vivo and ex vivo engineered T cell programs for B cell malignancies. Technology expected to help address key relapse challenges for CD19-directed CAR T cell therapies. SEATTLE, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering …SEATTLE, Dec. 11, 2022 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, shared data in six presentations at the 64 th American Society of Hematology (ASH) Annual Meeting and Exposition, taking place from Saturday, December 10 to Tuesday, …Aug 4, 2022 · Research and development expenses for the three and six months ended June 30, 2022 include non-cash stock-based compensation of $7.4 million and $13.1 million, respectively, and $3.1 million and ...

The CABA stock price is -20.72% off its 52-week high price of $19.34 and 72.35% above the 52-week low of $4.43. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.71 million shares traded.Sana Biotechnology also has data from the lead CAR-T molecule SC291’s Phase 1 study expected in 4Q23 and a cash position of $325.9 million, making it an attractive investment opportunity with a ...

Apr 17, 2023 · Sana Biotechnology, Inc. ( NASDAQ: SANA) is a small (closing in on $1 billion market cap) biotechnology company focused on developing gene and cell therapies for various diseases. The 5-year old ... Today, Sana is a public company. It did raise prodigious sums, $700 million in a Series A and another $585 million in an IPO. Yet disease — well, disease remains with us. The biotech’s hopes ...Get the latest Sana Biotechnology Inc (SANA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Join Us - Sana Biotechnology. We think about. medicine differently. We never lose sight of why our work matters – the potential to impact the lives of patients is important to everyone at Sana. As we push the bounds of scientific discovery, we recognize there will be obstacles and setbacks, but we remain resilient in pursuit of our mission.Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing ex vivo and in vivo cell engineering platforms to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, and genetic disorders, among ...The average price point forecasted by analysts for Sana Biotechnology Inc (SANA) is $8.80, which is $4.5 above the current market price. The public float for SANA is 98.88M, and currently, short sellers hold a 21.85% ratio of that float. The average trading volume of SANA on November 29, 2023 was 1.28M shares. SANA) stock’s latest price updateMay 24, 2023 · In a report released today, Emily Bodnar from H.C. Wainwright reiterated a Hold rating on Sana Biotechnology ( SANA – Research Report ). The company’s shares closed yesterday at $7.09. Bodnar ...

SANA stock forecast for 2023 – 2027. Last updated: August 4, 2023. SANA. Sana Biotechnology, Inc. 5.43 D 2.86% (0.16) Are you interested in Sana Biotechnology, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the SANA stock price in 2022-2027. Is SANA a good long term stock?

Company profile for Sana Biotechnology Inc. including key executives, insider trading, ownership, revenue and average growth rates. ... Stock Movers: Gainers, decliners and most actives market ...

Get the latest Sana Biotechnology, Inc. (SANA) stock news and headlines to help you in your trading and investing decisions. SEATTLE, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients thro...Sana Biotechnology (NASDAQ:SANA) is a biotechnology company building a platform for in vivo and ex vivo cell engineering. The company got started in 2018 with over $100Ms raised on day one ...SEATTLE, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will ...The whole human proteome may be free to browse thanks to DeepMind, but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. Glyphic Biotechnologies accelerates the critical but sl...Apr 13, 2023 · SANA Price Action: Sana Biotechnology has a 52-week high of 9.59 and a 52-week low of $2.99. Sana Biotechnology shares are up 26.4% at $4.74 at the time of writing, according to Benzinga Pro ... The latest is Sana Biotechnology, ... In a common trajectory, the company’s stock was trading at $4.71 at market close yesterday, a steep drop from the almost $40 share price Sana entered the ...Feb 4, 2021 · Sana Biotechnology raised $587.5 million in an initial public offering, ... the company confirmed that gross proceeds from the stock sale were $675.6 million. Steve Harr of Sana. The Sana Biotechnology, Inc. stock price gained 7.14% on the last trading day (Friday, 17th Nov 2023), rising from $3.92 to $4.20. During the last trading day the stock fluctuated 9.62% from a day low at $3.90 to a day high of $4.28. The price has risen in 6 of the last 10 days and is up by 18.98% over the past 2 weeks.Dr. Douglas E. Williams as Head of Research and Development Dr. Gary Meininger as Chief Medical Officer SEATTLE, April 10, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a ...1.45%. $369.91M. SANA | Complete Sana Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Sana Biotechnology has a new $50 million tool in its toolbox. Sana signed an agreement with Beam Therapeutics for non-exclusive commercial rights to the Cambridge, Mass.-based biotech’s gene ...Oct 11, 2023 · Seattle-based Sana went public just as the biotech stock market peaked in February 2021, enabling it to raise $587.5 million before entering the clinic. The stock has followed the broader market ... What's Happening With Sana Biotechnology Inc Stock Today? Sana Biotechnology Inc (SANA) stock has risen 3.47% while the S&P 500 is lower by -0.7% as of 1:01 PM on Friday, Apr 14. SANA has risen $0.17 from the previous closing price of $4.90 on volume of 1,193,832 shares. Over the past year the S&P 500 has fallen -6.27% while SANA is lower by ...Shares of Sana Biotechnology are trading up 2.83% over the last 24 hours, at $4.73 per share. A move to $13.00 would account for a 174.84% increase from the current share price. About Sana ...Instagram:https://instagram. best small cap fundsbest forex brokers in the ushow to sell stocks on etradetcrt stock forecast If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti... what are the best reitsbest stock advisor app Sana Biotechnology Announces Five Presentations at the 65th American Society of Hematology Annual Meeting. SEATTLE, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that five abstracts will have poster …Complete Sana Biotechnology Inc. stock information by Barron's. View real-time SANA stock price and news, along with industry-best analysis. best stock charting app Company profile for Sana Biotechnology Inc. including key executives, insider trading, ownership, revenue and average growth rates. ... Stock Movers: Gainers, decliners and most actives market ...Apr 10, 2023 · Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing ex vivo and in vivo cell engineering platforms to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, and genetic disorders, among ... 1.45%. $369.91M. SANA | Complete Sana Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.